C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) C07K 14/47 (2006.01) C12N 15/63 (2006.01) C12N 15/86 (2006.01) C12Q 1/68 (2006.01) A61K 38/17 (2006.01)
Patent
CA 2373466
The present invention provides an aprataxin gene involved in early-onset spinocerebellar ataxia with ocular motor apraxia and hypoalbuminemia (EAOH) and a protein encoded by the gene; and application of a mutant aprataxin gene involved in the onset of EAOH and a protein encoded by the mutant gene to treatment and diagnosis of the disease. The present invention also provides a human aprataxin protein or a gene for treatment of early-onset spinocerebellar ataxia with ocular motor apraxia and hypoalbuminemia (EAOH); and a human aprataxin gene DNA or fragments thereof for detecting EAOH.
Athena Diagnostics Inc.
President Of Niigata University
Smart & Biggar
LandOfFree
Application of aprataxin gene to diagnosis and treatment for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Application of aprataxin gene to diagnosis and treatment for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Application of aprataxin gene to diagnosis and treatment for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1720747